Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $375.7400 (-0.69%) ($375.4900 - $381.4725) on Mon. Jul. 11, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.25% (three month average) | | RSI | 60 | | Latest Price | $375.7400(-0.69%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.9% a day on average for past five trading days. | | Weekly Trend | REGN advances 3.5% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(62%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | | Factors Impacting REGN price | REGN will decline at least -1.125% in a week (0% probabilities).
VIXM(-9%) UUP(-7%) TLT(-7%) IPO(-6%) IBUY(-4%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.125% (StdDev 2.25%) | | Hourly BBV | 0 () | | Intraday Trend | -1.3% | | | | | |
|
| 5 Day Moving Average | $371.34(1.18%) | | 10 Day Moving Average | $359.26(4.59%) | | 20 Day Moving Average | $357.74(5.03%) | | To recent high | -11% | | To recent low | 13.5% | | Market Cap | $39.839b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |